A detailed history of Tributary Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Tributary Capital Management, LLC holds 1,998 shares of AMGN stock, worth $579,220. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,998
Previous 2,063 3.15%
Holding current value
$579,220
Previous $644,000 0.16%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$309.38 - $337.38 $20,109 - $21,929
-65 Reduced 3.15%
1,998 $643,000
Q2 2024

Jul 24, 2024

SELL
$262.75 - $319.31 $28,902 - $35,124
-110 Reduced 5.06%
2,063 $644,000
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $137,123 - $165,525
510 Added 30.67%
2,173 $617,000
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $425,229 - $479,708
1,663 New
1,663 $478,000
Q2 2018

Jul 25, 2018

BUY
$166.05 - $186.51 $664,200 - $746,040
4,000 New
4,000 $738,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tributary Capital Management, LLC Portfolio

Follow Tributary Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.